User profiles for David Wullimann
 | David WullimannKarolinska Institutet Verified email at ki.se Cited by 2416 |
[PDF][PDF] Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19
…, H Kamal, G Bogdanovic, S Muschiol, DJ Wullimann… - Cell, 2020 - cell.com
SARS-CoV-2-specific memory T cells will likely prove critical for long-term immune
protection against COVID-19. Here, we systematically mapped the functional and phenotypic …
protection against COVID-19. Here, we systematically mapped the functional and phenotypic …
Safety and efficacy of the mRNA BNT162b2 vaccine against SARS-CoV-2 in five groups of immunocompromised patients and healthy controls in a prospective open …
…, G Söderdahl, A Österborg, CIE Smith, D Wullimann… - …, 2021 - thelancet.com
Background Patients with immunocompromised disorders have mainly been excluded from
clinical trials of vaccination against COVID-19. Thus, the aim of this prospective clinical trial …
clinical trials of vaccination against COVID-19. Thus, the aim of this prospective clinical trial …
[PDF][PDF] Immunodeficiency syndromes differentially impact the functional profile of SARS-CoV-2-specific T cells elicited by mRNA vaccination
Many immunocompromised patients mount suboptimal humoral immunity after SARS-CoV-2
mRNA vaccination. Here, we assessed the single-cell profile of SARS-CoV-2-specific T …
mRNA vaccination. Here, we assessed the single-cell profile of SARS-CoV-2-specific T …
Functional SARS-CoV-2 cross-reactive CD4+ T cells established in early childhood decline with age
M Humbert, A Olofsson, D Wullimann… - Proceedings of the …, 2023 - National Acad Sciences
Pre-existing SARS-CoV-2-reactive T cells have been identified in SARS-CoV-2-unexposed
individuals, potentially modulating COVID-19 and vaccination outcomes. Here, we provide …
individuals, potentially modulating COVID-19 and vaccination outcomes. Here, we provide …
MAIT cell compartment characteristics are associated with the immune response magnitude to the BNT162b2 mRNA anti-SARS-CoV-2 vaccine
…, T Parrot, Y Gao, E Mouchtaridi, D Wullimann… - Molecular …, 2022 - Springer
Mucosa-associated invariant T (MAIT) cells are unconventional T cells with innate-like capacity
to rapidly respond to microbial infection via MR1-restricted antigen recognition. Emerging …
to rapidly respond to microbial infection via MR1-restricted antigen recognition. Emerging …
NK cell frequencies, function and correlates to vaccine outcome in BNT162b2 mRNA anti-SARS-CoV-2 vaccinated healthy and immunocompromised individuals
Adaptive immune responses have been studied extensively in the course of mRNA vaccination
against COVID-19. Considerably fewer studies have assessed the effects on innate …
against COVID-19. Considerably fewer studies have assessed the effects on innate …
Elevated CD21low B Cell Frequency Is a Marker of Poor Immunity to Pfizer-BioNTech BNT162b2 mRNA Vaccine Against SARS-CoV-2 in Patients with Common …
Purpose Limited data is available on the effect of COVID-19 vaccination in immunocompromised
individuals. Here, we provide the results from vaccinating a single-center cohort of …
individuals. Here, we provide the results from vaccinating a single-center cohort of …
Real-world assessment of immunogenicity in immunocompromised individuals following SARS-CoV-2 mRNA vaccination: a one-year follow-up of the prospective …
…, CIE Smith, J Vesterbacka, D Wullimann… - …, 2023 - thelancet.com
Background Immunocompromised patients have varying responses to SARS-CoV-2 mRNA
vaccination. However, there is limited information available from prospective clinical trial …
vaccination. However, there is limited information available from prospective clinical trial …
Hybrid immunity in immunocompromised patients with CLL after SARS-CoV-2 infection followed by booster mRNA vaccination
L Blixt, Y Gao, D Wullimann… - Blood, The Journal …, 2022 - ashpublications.org
COI notes: The authors declare no competing financial interests. MB is a consultant for Oxford
Immunotech. AS is a consultant for Gritstone Bio, Flow Pharma, Arcturus Therapeutics, …
Immunotech. AS is a consultant for Gritstone Bio, Flow Pharma, Arcturus Therapeutics, …
[HTML][HTML] T-cell immune responses following vaccination with mRNA BNT162b2 against SARS-CoV-2 in patients with chronic lymphocytic leukemia: results from a …
Significance between time points with missing values was assessed using Kruskal-Wallis test
with Dunn’s posttest. Correlation analysis was done using non-parametric Spearman rank …
with Dunn’s posttest. Correlation analysis was done using non-parametric Spearman rank …
